Accelerate Diagnostics Inc. (AXDX)

13.69
0.54 3.79
NASDAQ : Health Technology
Prev Close 14.23
Open 14.37
Day Low/High 13.64 / 14.50
52 Wk Low/High 12.70 / 30.35
Volume 371.45K
Avg Volume 331.70K
Exchange NASDAQ
Shares Outstanding 54.20M
Market Cap 766.92M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Noteworthy Friday Option Activity: AXDX, BIO, URI

Noteworthy Friday Option Activity: AXDX, BIO, URI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc , where a total of 2,048 contracts have traded so far, representing approximately 204,800 underlying shares. That amounts to about 48.3% of AXDX's average daily trading volume over the past month of 424,320 shares.

AXDX: Insiders Vs. Shorts

AXDX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 10/31/2018 settlement date, and Accelerate Diagnostics Inc is one of the most shorted stocks of the Russell 3000, based on 37.62 "days to cover" versus the median component at 4.44. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Accelerate Diagnostics Is Now Oversold (AXDX)

Accelerate Diagnostics Is Now Oversold (AXDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Thursday Option Activity: AXDX, HTZ, AYX

Notable Thursday Option Activity: AXDX, HTZ, AYX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Accelerate Diagnostics Inc , where a total volume of 2,263 contracts has been traded thus far today, a contract volume which is representative of approximately 226,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 56.5% of AXDX's average daily trading volume over the past month, of 400,380 shares.

Accelerate Diagnostics Reports Q3 2018 Financial Results

Accelerate Diagnostics Reports Q3 2018 Financial Results

Revenue Placements up 40 Percent in U.S., Total Revenue up 64 Percent

Accelerate Diagnostics Reports Q2 2018 Financial Results

Accelerate Diagnostics Reports Q2 2018 Financial Results

Revenue up 142 Percent, Global install base up 25 Percent

Notable Thursday Option Activity: AXDX, VIRT, CRC

Notable Thursday Option Activity: AXDX, VIRT, CRC

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc , where a total of 2,406 contracts have traded so far, representing approximately 240,600 underlying shares. That amounts to about 79.9% of AXDX's average daily trading volume over the past month of 301,220 shares.

First Week Of January 2018 Options Trading For Accelerate Diagnostics (AXDX)

First Week Of January 2018 Options Trading For Accelerate Diagnostics (AXDX)

Investors in Accelerate Diagnostics Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AXDX options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Accelerate Diagnostics Stock Sees Short Interest Decline 13.2%

Accelerate Diagnostics Stock Sees Short Interest Decline 13.2%

The most recent short interest data has been released for the 09/29/2017 settlement date, which shows a 1,616,902 share decrease in total short interest for Accelerate Diagnostics Inc , to 10,617,802, a decrease of 13.22% since 09/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of October 20th Options Trading For Accelerate Diagnostics (AXDX)

First Week of October 20th Options Trading For Accelerate Diagnostics (AXDX)

Investors in Accelerate Diagnostics Inc saw new options become available this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AXDX options chain for the new October 20th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D (Sell)